These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The susceptibility of the fetus and child to chemical pollutants. Animal tests to screen for human teratogens. Sullivan FM Pediatrics; 1974 May; 53(5):822-3. PubMed ID: 4416518 [No Abstract] [Full Text] [Related]
5. What is a human teratogen: clinical and epidemiological criteria. Bertollini R; Pagano M; Mastroiacovo P Ann Ist Super Sanita; 1993; 29(1):97-104. PubMed ID: 8129277 [TBL] [Abstract][Full Text] [Related]
7. Human teratogens and evidence-based teratogen risk counseling: the Motherisk approach. Nava-Ocampo AA; Koren G Clin Obstet Gynecol; 2007 Mar; 50(1):123-31. PubMed ID: 17304029 [TBL] [Abstract][Full Text] [Related]
8. Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Ornoy A Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988 [TBL] [Abstract][Full Text] [Related]
9. Development and standardization of screening methods for behavioral teratology. Buelke-Sam J; Kimmel CA Teratology; 1979 Aug; 20(1):17-29. PubMed ID: 515959 [No Abstract] [Full Text] [Related]
10. The role of postimplantation mammalian embryo culture in the study of teratogenic mechanisms. Steele CE Prog Clin Biol Res; 1985; 163C():271-6. PubMed ID: 3991630 [No Abstract] [Full Text] [Related]
12. Epidemiologic methods in the search for causes of human birth defects. Ferencz C; Loffredo C; Wilson PD Teratology; 2000 Apr; 61(4):243-5. PubMed ID: 10716741 [No Abstract] [Full Text] [Related]
13. The importance of epidemiology in identifying drugs which may cause malformations--with particular reference to drugs containing sex hormones. Kelsey FO Acta Morphol Acad Sci Hung; 1980; 28(1-2):189-95. PubMed ID: 7004099 [No Abstract] [Full Text] [Related]
14. [Identification of teratogenic risk factors by a case-control approach]. Calzolari E Pathologica; 1986; 78(1058):803-7. PubMed ID: 3696789 [No Abstract] [Full Text] [Related]
15. Risk minimization practices for pregnancy prevention: understanding risk, selecting tools. Uhl K; Trontell A; Kennedy D Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):337-48. PubMed ID: 16953517 [TBL] [Abstract][Full Text] [Related]
16. Birth defect surveillance in the search for and evaluation of possible human teratogens. Oakley GP J Environ Pathol Toxicol; 1978; 2(1):211-6. PubMed ID: 722223 [No Abstract] [Full Text] [Related]
17. Use of mammalian models in teratology. Palmer AK Prog Clin Biol Res; 1985; 163A():97-106. PubMed ID: 3969396 [No Abstract] [Full Text] [Related]
18. Natural teratogens in human foods and the chemistry of embryology. McLaughlin JL Prog Clin Biol Res; 1985; 163C():389-94. PubMed ID: 3991648 [No Abstract] [Full Text] [Related]
19. Mechanism of teratogenic action of thalidomide. Vaisman B Teratology; 1996 May; 53(5):283-4. PubMed ID: 8879085 [No Abstract] [Full Text] [Related]
20. Risk assessment of drug use in pregnancy: prevention of birth defects. Peters PW Ann Ist Super Sanita; 1993; 29(1):131-7. PubMed ID: 8129259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]